NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,341,000 | -37.6% | 482,600 | -19.6% | 0.50% | -54.9% |
| Q2 2018 | $3,750,000 | -24.7% | 600,000 | 0.0% | 1.10% | +9.5% |
| Q1 2018 | $4,980,000 | +62.7% | 600,000 | +100.0% | 1.01% | +40.4% |
| Q4 2017 | $3,060,000 | -16.4% | 300,000 | -25.0% | 0.72% | -7.6% |
| Q3 2017 | $3,660,000 | +0.3% | 400,000 | -20.0% | 0.78% | +2.4% |
| Q2 2017 | $3,650,000 | – | 500,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|